UBS Group’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
UBS Group's QGEN Position: Q3 2026 in Review
UBS Group reduced its Qiagen (QGEN) stake by 34% in Q3 2026, selling an estimated $49.3M and leaving 2,257,245 shares worth $98.8M. The position accounts for 0.01% of the portfolio, ranked #1103.
UBS Group first reported a position in QGEN in Q1 2017 and has held it in 39 quarters since. The position peaked at $215M in Q1 2020. 366 funds tracked by Wall St. Rank hold QGEN as of Q3 2026.
- UBS Group held 2,257,245 shares of Qiagen worth $98.8M as of Q3 2026.
- UBS Group sold 1,161,950 Qiagen shares in Q3 2026, an estimated $49.3M.
- Qiagen made up 0.01% of UBS Group's portfolio in Q3 2026, its #1103 holding.
- UBS Group first reported a position in Qiagen in Q1 2017 and has held it in 39 quarters since.
- UBS Group's Qiagen position peaked at $215M in Q1 2020.
- 366 funds tracked by Wall St. Rank held Qiagen as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.